The rationale of retinal endovascular fibrinolysis in the treatment of retinal vein occlusion: From experimental data to clinical application

Retina

Volumn 32, Issue 8, 2012, Pages 1566-1573

  Pournaras, Constantin J ^a   Petropoulos, Ioannis K ^a   Pournaras, Jean Antoine C ^b   Stangos, Alexandros N ^a,c   Gilodi, Nicole ^a   Rungger Brändle, Elisabeth ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

histology; microinjection; micropipette; minipig; puncture; retinal endovascular fibrinolysis; retinal vein occlusion; thrombin; tissue plasminogen activator

Indexed keywords

ALTEPLASE; BALANCED SALT SOLUTION; FLUORESCEIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARGON LASER; ARTICLE; CILIARY DISK; COLLATERAL CIRCULATION; CONTROLLED STUDY; FIBRINOLYSIS; HISTOLOGY; MICROPIPETTE; MINIPIG; NONHUMAN; PUNCH BIOPSY; REPERFUSION; RETINA VEIN OCCLUSION; RETINAL ENDOVASCULAR FIBRINOLYSIS; THROMBOGENESIS;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOVASCULAR PROCEDURES; FIBRINOLYSIS; FIBRINOLYTIC AGENTS; HEMOSTATICS; MICROINJECTIONS; PUNCTURES; REGIONAL BLOOD FLOW; REPERFUSION; RETINAL VEIN; RETINAL VEIN OCCLUSION; SCLEROSTOMY; SWINE; SWINE, MINIATURE; THROMBIN; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84865798662     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e318241ae55     Document Type: Article

References (41)

1. Quinlan PM, Elman MJ, Bhatt AK, et al. The natural course of central retinal vein occlusion. Am J Ophthalmol 1990;110: 118-123. (Pubitemid 20242332)
2. Central Vein Occlusion Study Group. Baseline and early natural history report: the Central Vein Occlusion Study. Arch Ophthalmol 1993;111:1087-1095.
3. Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486-491.
4. Green WR, Chan CC, Hutchins GM, Terry JM. Central retinal vein occlusion: a prospective histopathologic study of 29 eyes in 28 cases. Retina 1981;1:27-55. (Pubitemid 12160821)
5. Ottolander CJ, Craandijk A. Treatment of thrombosis of the central retinal vein with streptokinase. Thromb Diath Haemorrh 1968;20:415-419.
6. Kohner EM, Pettit JE, Hamilton AM, et al. Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J 1976;1:550-553.
7. Reim M, Bertram B, Wolf S. Treatment trials of plasminogen activator (rt-PA) in central retinal vein thrombosis of the retina [in German]. Klin Wochenschr 1988;66:143-149. (Pubitemid 18093871)
8. Steinkamp GW, Hattenbach LO, Scharrer I, Ohrloff C. Frontloading rt PA thrombolytic therapy in central or venous branch occlusions of the retina [in German]. Ophthalmologe 1994;91: 280-282.
9. Elman MJ. Thrombolytic therapy for central retinal vein occlusion: results of a pilot study. Trans Am Ophthalmol Soc 1996;94:471-504. (Pubitemid 26406044)
10. Hattenbach LO, Steinkamp GW, Scharrer I, Ohrloff C. Fibrinolytic therapy with low-dose recombinant tissue plasminogen activator in retinal vein occlusion. Ophthalmologica 1998;212: 394-398. (Pubitemid 28446596)
11. Hattenbach LO, Friedrich Arndt C, Lerche R, et al. Retinal vein occlusion and low-dose fibrinolytic therapy (R.O.L.F.): a prospective, randomized, controlled multicenter study of lowdose recombinant tissue plasminogen activator versus hemodilution in retinal vein occlusion. Retina 2009;29:932-940.
12. Paques M, Vallee JN, Herbreteau D, et al. Superselective ophthalmic artery fibrinolytic therapy for the treatment of central retinal vein occlusion. Br J Ophthalmol 2000;84:1387-1391.
13. Vallee JN, Paques M, Aymard A, et al. Combined central retinal arterial and venous obstruction: emergency ophthalmic arterial fibrinolysis. Radiology 2002;223:351-359. (Pubitemid 34454310)
14. Lahey JM, Fong DS, Kearney J. Intravitreal tissue plasminogen activator for acute central retinal vein occlusion. Ophthalmic Surg Lasers 1999;30:427-434. (Pubitemid 29279445)
15. Glacet-Bernard A, Kuhn D, Vine AK, et al. Treatment of recent onset central retinal vein occlusion with intravitreal tissue plasminogen activator: a pilot study. Br J Ophthalmol 2000;84: 609-613. (Pubitemid 30339312)
16. Elman MJ, Raden RZ, Carrigan A. Intravitreal injection of tissue plasminogen activator for central retinal vein occlusion. Trans Am Ophthalmol Soc 2001;99:219-221.
17. Ghazi NG, Noureddine B, Haddad RS, et al. Intravitreal tissue plasminogen activator in the management of central retinal vein occlusion. Retina 2003;23:780-784. (Pubitemid 38040577)
18. Johnson MW, Olsen KR, Hernandez E, et al. Retinal toxicity of recombinant tissue plasminogen activator in the rabbit. Arch Ophthalmol 1990;108:259-263. (Pubitemid 20058162)
19. Irvine WD, Johnson MW, Hernandez E, Olsen KR. Retinal toxicity of human tissue plasminogen activator in vitrectomized rabbit eye. Arch Ophthalmol 1991;109:718-722.
20. Hrach CJ, Johnson MW, Hassan AS, et al. Retinal toxicity of commercial intravitreal tissue plasminogen activator solution in cat eyes. Arch Ophthalmol 2000;118:659-663. (Pubitemid 30327343)
21. Hu YT, Ma ZZ, Zhang XL, et al. Experimental study of infusing tPA in retinal vein for treatment of retinal vein occlusion [in Chinese]. Zhonghua Yan Ke Za Zhi 2003;39:645-649.
22. Weiss JN. Treatment of central retinal vein occlusion by injection of tissue plasminogen activator into a retinal vein. Am J Ophthalmol 1998;126:142-144. (Pubitemid 28341235)
23. Weiss JN, Bynoe LA. Injection of tissue plasminogen activator into a branch retinal vein in eyes with central retinal vein occlusion. Ophthalmology 2001;108:2249-2257. (Pubitemid 33096938)
24. Bynoe LA, Hutchins RK, Lazarus HS, Friedberg MA. Retinal endovascular surgery for central retinal vein occlusion: initial experience of four surgeons. Retina 2005;25:625-632. (Pubitemid 41077268)
25. Yamamoto T, Kamei M, Sakaguchi H, et al. Comparison of surgical treatments for central retinal vein occlusion; RON vs. cannulation of tissue plasminogen activator into the retinal vein. Retina 2009;29:1167-1174.
26. Feltgen N, Junker B, Agostini H, Hansen LL. Retinal endovascular lysis in ischemic central retinal vein occlusion: oneyear results of a pilot study. Ophthalmology 2007;114: 716-723.
27. Hayreh SS. t-PA in CRVO. Ophthalmology 2002;109: 1758-1761.
28. Rootman J. Vascular system of the optic nerve head and retina in the pig. Br J Ophthalmol 1971;55:808-819.
29. Pournaras CJ, Riva CE, Tsacopoulos M, Strommer K. Diffusion of O2 in the retina of anesthetized miniature pigs in normoxia and hyperoxia. Exp Eye Res 1989;49:347-360. (Pubitemid 19239393)
30. Mendrinos E, Petropoulos IK, Mangioris G, et al. Lactateinduced retinal arteriolar vasodilation implicates neuronal nitric oxide synthesis in minipigs. Invest Ophthalmol Vis Sci 2008; 49:5060-5066.
31. Sakuraba T. Experimental retinal vein obstruction induced by transadventitial administration of thrombin in the rabbit [in Japanese]. Nippon Ganka Gakkai Zasshi 1989;93:978-985. (Pubitemid 19268753)
32. Allf BE, de Juan E, Jr. In vivo cannulation of retinal vessels. Graefes Arch Clin Exp Ophthalmol 1987;225:221-225.
33. Glucksberg MR, Dunn R, Giebs CP. In vivo micropuncture of retinal vessels. Graefes Arch Clin Exp Ophthalmol 1993;231: 405-407. (Pubitemid 23258538)
34. Suzuki Y, Matsuhashi H, Nakazawa M. In vivo retinal vascular cannulation in rabbits. Graefes Arch Clin Exp Ophthalmol 2003;241:585-588. (Pubitemid 36975059)
35. Tsilimbaris MK, Lit ES, D'Amico DJ. Retinal microvascular surgery: a feasibility study. Invest Ophthalmol Vis Sci 2004; 45:1963-1968. (Pubitemid 38868995)
36. Christoforidis JB, Warden SM, DeMattia M, D'Amico DJ. In vivo redirection of retinal blood flow into borosilicate microcannulas in rabbits. Graefes Arch Clin Exp Ophthalmol 2006; 244:1022-1025. (Pubitemid 44184510)
37. Zhang X, Ma Z, Hu Y, Fan J. Direct tissue plasminogen activator administration through a microinjection device in a pig model of retinal vein thrombosis. Curr Eye Res 2002;24: 263-267. (Pubitemid 35155741)
38. Tameesh MK, Lakhanpal RR, Fujii GY, et al. Retinal vein cannulation with prolonged infusion of tissue plasminogen activator (t-PA) for the treatment of experimental retinal vein occlusion in dogs. Am J Ophthalmol 2004;138: 829-839. (Pubitemid 39452931)
39. Shahid H, Hossain P, Amoaku WM. The management of retinal vein occlusion: is interventional ophthalmology the way forward? Br J Ophthalmol 2006;90:627-639.
40. Pournaras CJ, Rungger-Brändle E, Riva CE, et al. Regulation of retinal blood flow in health and disease. Prog Retin Eye Res 2008;27:284-330.
41. Loren M, García Frade LJ, Torrado MC, Navarro JL. Thrombus age and tissue plasminogen activator mediated thrombolysis in rats. Thromb Res 1989;56:67-75.